| Status | Study |
| Recruiting |
Study Name: Oral Tofacitinib in Adult Subjects With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Condition: Discoid Lupus Erythematosus Systemic Lupus Erythematosus Date: 2017-05-02 Interventions: Biological: Tofacitinib citrate 10 mg daily by mouth |
| Recruiting |
Study Name: Targeted Therapy Using Intradermal Injection of Etanercept for Remission Induction in Discoid Lupus Erythematosus Condition: Lupus Erythematosus, Discoid Lupus Erythematosus, Cutaneous Date: 2016-01-08 Interventions: Drug: Etanercept Treatment with etanercept is intended for remission induction of DLE only and not for m |
| Active, not recruiting |
Study Name: Autologous Polyclonal Tregs for Lupus Condition: Lupus Erythematosus, Cutaneous Lupus Erythematosus, Discoid Date: 2015-04-23 Interventions: Biological: Ex vivo Expanded Human Autologous Polyclonal Regulatory T Cells Other Name: Ex vivo Expanded |
| Completed |
Study Name: Pilot Tape Harvesting Study Condition: Atopic Dermatitis Healthy Discoid Lu Date: 2014-04-25 Interventions: Procedure: Skin Taping Skin ta |
| Completed |
Study Name: A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers Condition: Lupus Erythematosus, Cutaneous Lupus Erythematosus, Systemic Date: 2013-12-10 Interventions: Procedure: Skin biopsy Partici |
| Completed |
Study Name: A Non-drug Study Profiling Cutaneous Lupus Condition: Lupus Erythematosus, Cutaneous Lupus Erythematosus, Systemic Date: 2013-08-12 Interventions: Procedure: No intervention, skin biopsy |
| Recruiting |
Study Name: Phase Ib Study of SC Milatuzumab in SLE Condition: Lupus Erythematosus, Cutaneous Lupus Erythematosus, Discoid Date: 2013-04-17 Interventions: Drug: milatuzumab Milatuzumab |
| Completed |
Study Name: A Pooled Analysis of the HGS1006-C1056 (BLISS-52) and HGS1006-C1057 (BLISS-76) Studies Condition: Lupus Erythematosus, Discoid Date: 2012-12-19 Interventions: Drug: Belimumab 1 mg/kg Belimu |
| Completed |
Study Name: Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Lesions Condition: Lupus Erythematosus, Discoid Lupus Erythematosus, Systemic Date: 2012-05-09 Interventions: Drug: R932333 R393233 6% (60 m |
| Terminated |
Study Name: A Research Study to Assess if CC-930 is Safe in Treating Subjects With Discoid Lupus Erythematosus Condition: Discoid Lupus Date: 2011-11-04 Interventions: Drug: CC-930 Drug: Placebo |